Literature DB >> 15850755

An assay to compare the infectivity of Mycobacterium tuberculosis isolates based on aerosol infection of guinea pigs and assessment of bacteriology.

Ann Williams1, Brian W James, Joanna Bacon, Kim A Hatch, Graham J Hatch, Graham A Hall, Philip D Marsh.   

Abstract

The aim of this study was to establish an assay to compare Mycobacterium tuberculosis strains, and cells grown under different growth conditions, in terms of their ability to cause a lung infection and disseminate to the spleen. M. tuberculosis strains H37Rv, Erdman, South Indian (TMC120, SI) and H37Rv cells grown aerobically or under low oxygen/iron limitation in a chemostat were assayed for infectivity. Groups of 8 animals were challenged with 3 different doses of each strain. Lung and spleen bacteriology was assessed at 16 days post-infection for all strains. Bacteriology and lung pathology at day 56 was studied for H37Rv, Erdman and SI. Strains H37Rv and Erdman had a statistically significantly higher pathogenic potential than SI and this was confirmed by analysis of lung pathology performed at 8 weeks post-infection, although the Erdman strain caused more extensive caseation without calcification and little encapsulation. The model could discriminate between cells grown under different growth conditions; low-oxygen/iron-limited cells had a significantly higher infectivity than those grown aerobically. This study presents a quick and reliable method for comparing with statistical confidence, the pathogenic potential of M. tuberculosis strains and the impact of in vitro growth conditions on the infectivity of M. tuberculosis in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15850755     DOI: 10.1016/j.tube.2004.11.001

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  9 in total

1.  Does M. tuberculosis genomic diversity explain disease diversity?

Authors:  Mireilla Coscolla; Sebastien Gagneux
Journal:  Drug Discov Today Dis Mech       Date:  2010

Review 2.  Mycobacterium Tuberculosis and Interactions with the Host Immune System: Opportunities for Nanoparticle Based Immunotherapeutics and Vaccines.

Authors:  Raymonde B Bekale; Su-Mari Du Plessis; Nai-Jen Hsu; Jyoti R Sharma; Samantha L Sampson; Muazzam Jacobs; Mervin Meyer; Gene D Morse; Admire Dube
Journal:  Pharm Res       Date:  2018-11-08       Impact factor: 4.200

Review 3.  Genotyping of Mycobacterium tuberculosis: application in epidemiologic studies.

Authors:  Midori Kato-Maeda; John Z Metcalfe; Laura Flores
Journal:  Future Microbiol       Date:  2011-02       Impact factor: 3.165

Review 4.  Animal models of tuberculosis: Guinea pigs.

Authors:  Simon Clark; Yper Hall; Ann Williams
Journal:  Cold Spring Harb Perspect Med       Date:  2014-12-18       Impact factor: 6.915

5.  Construction and Characterization of the Mycobacterium tuberculosis sigE fadD26 Unmarked Double Mutant as a Vaccine Candidate.

Authors:  Rogelio Hernandez-Pando; Sung Jae Shin; Simon Clark; Stefano Casonato; Martin Becerril-Zambrano; Hongmin Kim; Francesca Boldrin; Dulce Mata-Espinoza; Roberta Provvedi; Ainhoa Arbues; Brenda Marquina-Castillo; Laura Cioetto Mazzabò; Jorge Barrios-Payan; Carlos Martin; Sang-Nae Cho; Ann Williams; Riccardo Manganelli
Journal:  Infect Immun       Date:  2019-12-17       Impact factor: 3.441

6.  Correlates between models of virulence for Mycobacterium tuberculosis among isolates of the Central Asian lineage: a case for lysozyme resistance testing?

Authors:  Claire Pardieu; Nicola Casali; Simon O Clark; Richard Hooper; Ann Williams; Preya Velji; Ximena Gonzalo; Francis Drobniewski
Journal:  Infect Immun       Date:  2015-03-16       Impact factor: 3.441

7.  Calcitriol enhances pyrazinamide treatment of murine tuberculosis.

Authors:  Jing Zhang; Ming Guo; Zhi-Xiang Huang; Rong Bao; Qian Yu; Ming Dai; Xin Wang; Yan Rao
Journal:  Chin Med J (Engl)       Date:  2019-09-05       Impact factor: 2.628

Review 8.  Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development.

Authors:  A Volz; G Sutter
Journal:  Adv Virus Res       Date:  2016-08-01       Impact factor: 9.937

9.  Assessment of Mycobacterium bovis deleted in p27-p55 virulence operon as candidate vaccine against tuberculosis in animal models.

Authors:  María V Bianco; Simon Clark; Federico C Blanco; Sergio Garbaccio; Elizabeth García; Angel A Cataldi; Ann Williams; Fabiana Bigi
Journal:  Biomed Res Int       Date:  2014-01-21       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.